Andreas Kluge
Fortune : 228 M $ au 31/08/2026
Fortune : 228 M $ au 31/08/2026
Andreas Kluge founded Therapeia GmbH & Co. Kg in 2007, where he is working as Chief Executive Officer from 2007, ABX-CRO advanced pharmaceutical services in 2002, where he is working as General Manager & Medical Director from 2002, ABX advanced biochemical compounds GmbH in 1996, where he worked as Chief Executive Officer from 1996 to 2002, and Telix Pharmaceuticals Ltd. in 2015, where he worked as Non-Executive Director from 2020 to 2024.
Dr. Kluge received his doctorate degree from Freie Universität Berlin.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/02/2026 | 20 675 000 ( 6,08 % ) | 228 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Provides diagnostic and therapeutic radiopharmaceuticals | Directeur Général | 01/01/2007 |
ABX-CRO advanced pharmaceutical services | Fondateur | 01/08/2002 |
| Sociétés | Poste | Fin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Fondateur | 17/10/2024 |
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Manufactures chemicals for nuclear medicine applications | Directeur Général | 01/07/2002 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Manufactures chemicals for nuclear medicine applications | Process Industries |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Provides diagnostic and therapeutic radiopharmaceuticals | Health Technology |
ABX-CRO advanced pharmaceutical services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national